Regal Assets Analytics

GEO Investing

Ibio (AMEX:IBIO) Price Movement From Ebola/Enterovirus Hype Ibio (AMEX:IBIO) ($1.47) is a leading provider of plant-based biotechnology for developing and manufacturing biological products.  As expected, the hype surrounding the Ebola and Enterorvirus outbreaks in the U.S. will inevitably led to aggressive share price […]

Summary We offer a rebuttal to all four of XXII’s counterarguments to our piece published Wednesday (yesterday) morning. Rather than worry about the nuanced arguments XXII made in its rebuttal, we believe investors should be more interested in what XXII […]

While doing our research, we’ve noted a lot of company press releases that seem impressive on the surface, but that have all ultimately led to where the company is now-poised for more dilution and continually posting losses. When considering whether […]